Financhill
Back

Guardant Health Quote, Financials, Valuation and Earnings

Guardant Health Price Quote

$31.94

Guardant Health Key Stats

Sell
46
Guardant Health (GH) is a Sell

Day range:
$30.59 - $32.52
52-week range:
$24.63 - $78.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.56
P/B ratio:
19.62%

Volume:
1.9M
Avg. volume:
1.8M
1-year change:
-55.07%
Market cap:
$3.3B
Revenue:
$373.7M
EPS:
$-5.93

How Much Does Guardant Health Make?

Is Guardant Health Growing As A Company?

  • What Is Guardant Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.24%
  • What Is Guardant Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Guardant Health Stock Price Performance

  • Did Guardant Health Stock Go Up Last Month?
    Guardant Health share price went up by 18.3% last month
  • Did GH's Share Price Rise Over The Last Year?
    GH share price fell by -55.07% over the past 1 year

What Is Guardant Health 52-Week High & Low?

Guardant Health Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Guardant Health?

  • How Much Debt Does Guardant Health Have?
    Total long term debt quarterly is $1.1B
  • How Much Cash Does Guardant Health Have?
    Cash and short term investments quarterly total is $958M
  • What Is Guardant Health’s Book Value Per Share?
    Book value per share is 1.63

Is Guardant Health Cash Flow Positive?

  • What Is GH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$295.7M
  • What Is Guardant Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$187.6M
  • What Is Guardant Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$187.5M

Guardant Health Return On Invested Capital

  • Is Management Doing A Good Job?
    GH return on invested capital is -37.33%
  • What Is Guardant Health Return On Assets?
    ROA measures how assets are converting to revenues and is -29.93%
  • What Is GH Return On Equity?
    ROE is a measure of profitability and is -127.58%

Guardant Health Earnings Date & Stock Price

Guardant Health Competitors

Guardant Health Dividend Yield

Data Unavailable

Guardant Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -8.78%
Revenue: 23.87% -0.37%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 65.13
Upside from Last Price: 103.9%

Major Shareholders

  • How many GH shares are owned by institutional investors?
    163.8M GH shares are owned by institutional investors
  • How many GH shares are owned by insiders?
    4.1M GH shares are owned by insiders